Adjusting Overall Survival Estimates of Macitentan in Pulmonary Arterial Hypertension After Treatment Switching: Results from the SERAPHIN Study

por Di Scala, Lilla, Bacchi, Marisa, Bayer, Bjørn, Turricchia, Stefano
Publicado 2022

Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial

por Beeh, Kai M, Singh, Dave, Di Scala, Lilla, Drollmann, Anton
Publicado 2012

Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension

por Jansa, Pavel, Ambrož, David, Aschermann, Michael, Černý, Vladimír, Dytrych, Vladimír, Heller, Samuel, Kunstýř, Jan, Lindner, Jaroslav, Linhart, Aleš, Nižnanský, Matúš, Paďour, Michal, Prskavec, Tomáš, Širanec, Michal, Edwards, Susan, Gressin, Virginie, Kuhn, Matyáš, Di Scala, Lilla
Publicado 2022

Correction: Jansa et al. Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension. J. Clin. Med. 2022, 11, 6189

por Jansa, Pavel, Ambrož, David, Aschermann, Michael, Černý, Vladimír, Dytrych, Vladimír, Heller, Samuel, Kunstýř, Jan, Lindner, Jaroslav, Linhart, Aleš, Nižnanský, Matúš, Pad’our, Michal, Prskavec, Tomáš, Širanec, Michal, Edwards, Susan, Gressin, Virginie, Kuhn, Matyáš, Di Scala, Lilla
Publicado 2023

Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension

por Gaine, Sean, Chin, Kelly, Coghlan, Gerry, Channick, Richard, Di Scala, Lilla, Galiè, Nazzareno, Ghofrani, Hossein-Ardeschir, Lang, Irene M., McLaughlin, Vallerie, Preiss, Ralph, Rubin, Lewis J., Simonneau, Gérald, Sitbon, Olivier, Tapson, Victor F., Hoeper, Marius M.
Publicado 2017

Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension: Insights From the Phase III GRIPHON Study

por Chin, Kelly M., Rubin, Lewis J., Channick, Richard, Di Scala, Lilla, Gaine, Sean, Galiè, Nazzareno, Ghofrani, Hossein-Ardeschir, Hoeper, Marius M., Lang, Irene M., McLaughlin, Vallerie V., Preiss, Ralph, Simonneau, Gérald, Sitbon, Olivier, Tapson, Victor F.
Publicado 2019

Targeting the Prostacyclin Pathway with Selexipag in Patients with Pulmonary Arterial Hypertension Receiving Double Combination Therapy: Insights from the Randomized Controlled GRI...

por Coghlan, J. Gerry, Channick, Richard, Chin, Kelly, Di Scala, Lilla, Galiè, Nazzareno, Ghofrani, Hossein-Ardeschir, Hoeper, Marius M., Lang, Irene M., McLaughlin, Vallerie, Preiss, Ralph, Rubin, Lewis J., Simonneau, Gérald, Sitbon, Olivier, Tapson, Victor F., Gaine, Sean
Publicado 2018

Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study

por Beghetti, Maurice, Channick, Richard N., Chin, Kelly M., Di Scala, Lilla, Gaine, Sean, Ghofrani, Hossein‐Ardeschir, Hoeper, Marius M., Lang, Irene M., McLaughlin, Vallerie V., Preiss, Ralph, Rubin, Lewis J., Simonneau, Gérald, Sitbon, Olivier, Tapson, Victor F., Galiè, Nazzareno
Publicado 2019